Panel discussion; SGLT2 in clinical cardiology.
Topic:
Primary cardiovascular prevention: interventions and outcomes
Speaker:
Professor S. Anker (Berlin, DE)
Professor N. Sattar (Glasgow, GB)
Professor J. Deanfield (London, GB)
Doctor D. Fitchett (Toronto, CA)
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Boehringer Ingelheim/Lilly
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Professor Stefan Anker
Charite University Hospital, Berlin (Germany)
159
presentations
8
followers
Professor Naveed Sattar
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
42
presentations
2
followers
Professor John Eric Deanfield
University College London, London (United Kingdom of Great Britain & Northern Ireland)
50
presentations
3
followers
Doctor David Fitchett
St. Michael's Hospital, Toronto (Canada)
18
presentations
0
follower
2 more presentations in this session
Introduction - Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure.
Speaker: Professor J. Deanfield (London, GB)
SGLT2 inhibition in cardiology: what a cardiologist needs to know.
Speaker: Professor N. Sattar (Glasgow, GB)
Access the full session
Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)
Speakers:
Professor S. Anker, Professor N. Sattar, Professor J. Deanfield, Doctor D. Fitchett, Professor J. Deanfield...
About the event
ESC 365 is supported by
